These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 19908075)

  • 21. Protective immune barrier against hepatitis B is needed in individuals born before infant HBV vaccination program in China.
    Yang S; Yu C; Chen P; Deng M; Cao Q; Li Y; Ren J; Xu K; Yao J; Xie T; Wang C; Cui Y; Ding C; Tian G; Wang B; Zhang X; Ruan B; Li L
    Sci Rep; 2015 Dec; 5():18334. PubMed ID: 26655735
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Distinct geographical and demographic distribution of hepatitis B virus genotypes in the Canadian Arctic as revealed through an extensive molecular epidemiological survey.
    Osiowy C; Larke B; Giles E
    J Viral Hepat; 2011 Apr; 18(4):e11-9. PubMed ID: 20723037
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Universal Infant Hepatitis B Virus (HBV) Vaccination for 35 Years: Moving Toward the Eradication of HBV.
    Chang KC; Chang MH; Chen HL; Wu JF; Chang CH; Hsu HY; Ni YH
    J Infect Dis; 2022 Feb; 225(3):431-435. PubMed ID: 34363469
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatitis B virus seroepidemiology data for Africa: Modelling intervention strategies based on a systematic review and meta-analysis.
    McNaughton AL; Lourenço J; Bester PA; Mokaya J; Lumley SF; Obolski U; Forde D; Maponga TG; Katumba KR; Goedhals D; Gupta S; Seeley J; Newton R; Ocama P; Matthews PC
    PLoS Med; 2020 Apr; 17(4):e1003068. PubMed ID: 32315297
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acute hepatitis B 14 years after the implementation of universal vaccination in Italy: areas of improvement and emerging challenges.
    Mele A; Tosti ME; Mariano A; Pizzuti R; Ferro A; Borrini B; Zotti C; Lopalco P; Curtale F; Balocchini E; Spada E;
    Clin Infect Dis; 2008 Mar; 46(6):868-75. PubMed ID: 18269332
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical characteristics of hepatitis B virus infection in middle school students born after the universal infant vaccination program in Shanghai, China.
    Wang WL; Shu ZJ; Zhou LX; Zhao YR
    Arch Virol; 2012 May; 157(5):901-5. PubMed ID: 22327392
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epidemiology of hepatitis B and hepatitis B virus infection in United States children.
    Shepard CW; Finelli L; Fiore AE; Bell BP
    Pediatr Infect Dis J; 2005 Sep; 24(9):755-60. PubMed ID: 16148839
    [TBL] [Abstract][Full Text] [Related]  

  • 28. From infancy and beyond… ensuring a lifetime of hepatitis B virus (HBV) vaccine-induced immunity.
    Osiowy C
    Hum Vaccin Immunother; 2018; 14(8):2093-2097. PubMed ID: 29641290
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatitis B virus (HBV) infection amongst children in Senegal: current prevalence and seroprotection level.
    Lô G; Sow-Sall A; Diop-Ndiaye H; Babacar N; Diouf NN; Daffé SM; Ndao B; Thiam M; Mbow M; Soumboundou MB; Lemoine M; Sylla-Niang M; Ndiaye O; Boye CS; Mboup S; Touré-Kane NC
    Pan Afr Med J; 2019; 32():140. PubMed ID: 31303913
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [China's hepatitis B burden and expectation on 40 years of trials and tribulations].
    Cai DC; Ren H
    Zhonghua Gan Zang Bing Za Zhi; 2019 Jan; 27(1):3-5. PubMed ID: 30685915
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An assessment of the effect of hepatitis B vaccine in decreasing the amount of hepatitis B disease in Italy.
    La Torre G; Nicolotti N; de Waure C; Chiaradia G; Specchia ML; Mannocci A; Ricciardi W
    Virol J; 2008 Jul; 5():84. PubMed ID: 18652653
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Residual risk of mother-to-child transmission of hepatitis B virus infection despite timely birth-dose vaccination in Cameroon (ANRS 12303): a single-centre, longitudinal observational study.
    Shimakawa Y; Veillon P; Birguel J; Pivert A; Sauvage V; Guillou-Guillemette HL; Roger S; Njouom R; Ducancelle A; Amta P; Huraux JM; Adoukara JP; Lunel-Fabiani F
    Lancet Glob Health; 2022 Apr; 10(4):e521-e529. PubMed ID: 35183302
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An epidemiological serosurvey of hepatitis B virus shows evidence of declining prevalence due to hepatitis B vaccination in central China.
    Yonghao G; Jin X; Jun L; Pumei D; Ying Y; Xiuhong F; Yanyang Z; Wanshen G
    Int J Infect Dis; 2015 Nov; 40():75-80. PubMed ID: 26456567
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Discovery of a Novel Mutation (X8Del) Resulting in an 8-bp Deletion in the Hepatitis B Virus X Gene Associated with Occult Infection in Korean Vaccinated Individuals.
    Kim H; Gong JR; Lee SA; Kim BJ
    PLoS One; 2015; 10(10):e0139551. PubMed ID: 26437447
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Hepatitis B vaccine and liver cancer].
    Lebossé F; Zoulim F
    Bull Cancer; 2021 Jan; 108(1):90-101. PubMed ID: 33358507
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Survey of Impediments to Prevention of Mother-to-infant Transmission of Hepatitis B Virus by International Societies.
    Chang MH; Fischler B; Blauvelt B; Ciocca M; Dhawan A; Ekong U; Ni YH; Porta G; Sibal A; DAgostino D; Wirth S; Morhan N; Schwarz KB
    J Pediatr Gastroenterol Nutr; 2019 Dec; 69(6):648-654. PubMed ID: 31503215
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence and risk factors of HBsAg in Gaza: implications for prevention and control.
    Yassin K; Awad R; Tebi AJ; Queder A; Laaser U
    J Infect; 2002 May; 44(4):252-6. PubMed ID: 12099733
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High prevalence of occult hepatitis B infection (OBI) among healthy children and their parents in Alborz province, Iran; Vertical OBI, myth or truth?
    Ghaziasadi A; Fakhari Z; Aghcheli B; Poortahmasebi V; Farahmand M; Norouzi M; Ghalichi L; Soleimani A; Hedayat Yaghoobi M; Ravanshad M; Jazayeri SM
    Liver Int; 2020 Jan; 40(1):92-100. PubMed ID: 31518482
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Selective hepatitis B virus vaccination has reduced hepatitis B virus transmission in the Netherlands.
    Hahné S; van Houdt R; Koedijk F; van Ballegooijen M; Cremer J; Bruisten S; Coutinho R; Boot H
    PLoS One; 2013; 8(7):e67866. PubMed ID: 23922651
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A mathematical model to estimate global hepatitis B disease burden and vaccination impact.
    Goldstein ST; Zhou F; Hadler SC; Bell BP; Mast EE; Margolis HS
    Int J Epidemiol; 2005 Dec; 34(6):1329-39. PubMed ID: 16249217
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.